eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, announced the close of a $191 million Series D financing....
Hansa Biopharma, "Hansa", pioneer in enzyme technology for rare immunological conditions, announces the recommendation by the National Institute for Health and Care Excellence (NICE)...
